CD8A and neoplasm: These cross‐resistant tumours have reduced CD8+ T‐cell infiltrates, downregulated an expression of T‐cell effector molecules and markers of activation, impaired maturation and functionality of CD103+ dendritic cells and increased immunosuppressive myeloid cells, all of which are supported by observations from other clinical data sets.45, 81, 82